Café

ORMP

4.1603.23%( +0.130 )

LongbridgeAI

ORMP

4.1603.23%( +0.130 )

Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet.

benzinga_article

Jun 25, 2026 at 12:03 PM

Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Scilex

USSCLX

+2.78%

Oramed Pharma

USORMP

+3.23%

LongbridgeAI

Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet.

benzinga_article

Jun 25, 2026 at 12:03 PM

Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

Related Stocks

Scilex

USSCLX

+2.78%

Oramed Pharma

USORMP

+3.23%